These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30089201)

  • 1. Structuring of Organic Solvents at Solid Interfaces and Ramifications for Antimalarial Adsorption on β-Hematin Crystals.
    Olafson KN; Clark RJ; Vekilov PG; Palmer JC; Rimer JD
    ACS Appl Mater Interfaces; 2018 Sep; 10(35):29288-29298. PubMed ID: 30089201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solvent Structure and Dynamics near the Surfaces of β-Hematin Crystals.
    Verma L; Vekilov PG; Palmer JC
    J Phys Chem B; 2021 Oct; 125(40):11264-11274. PubMed ID: 34609878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
    Olafson KN; Ketchum MA; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):4946-51. PubMed ID: 25831526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematin crystallization from aqueous and organic solvents.
    Ketchum MA; Olafson KN; Petrova EV; Rimer JD; Vekilov PG
    J Chem Phys; 2013 Sep; 139(12):121911. PubMed ID: 24089723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.
    Olafson KN; Nguyen TQ; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7531-7536. PubMed ID: 28559329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deconstructing Quinoline-Class Antimalarials to Identify Fundamental Physicochemical Properties of Beta-Hematin Crystal Growth Inhibitors.
    Olafson KN; Nguyen TQ; Vekilov PG; Rimer JD
    Chemistry; 2017 Oct; 23(55):13638-13647. PubMed ID: 28833627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adsorption to the Surface of Hemozoin Crystals: Structure-Based Design and Synthesis of Amino-Phenoxazine β-Hematin Inhibitors.
    Olivier T; Loots L; Kok M; de Villiers M; Reader J; Birkholtz LM; Arnott GE; de Villiers KA
    ChemMedChem; 2022 May; 17(10):e202200139. PubMed ID: 35385211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal nucleation, growth, and morphology of the synthetic malaria pigment beta-hematin and the effect thereon by quinoline additives: the malaria pigment as a target of various antimalarial drugs.
    Solomonov I; Osipova M; Feldman Y; Baehtz C; Kjaer K; Robinson IK; Webster GT; McNaughton D; Wood BR; Weissbuch I; Leiserowitz L
    J Am Chem Soc; 2007 Mar; 129(9):2615-27. PubMed ID: 17290993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoline antimalarials decrease the rate of beta-hematin formation.
    Egan TJ; Ncokazi KK
    J Inorg Biochem; 2005 Jul; 99(7):1532-9. PubMed ID: 15927260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization.
    Fitzroy SM; Gildenhuys J; Olivier T; Tshililo NO; Kuter D; de Villiers KA
    Langmuir; 2017 Aug; 33(30):7529-7537. PubMed ID: 28689414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of Large Hematin Crystals in Biomimetic Solutions.
    Olafson KN; Rimer JD; Vekilov PG
    Cryst Growth Des; 2014 May; 14(5):2123-2127. PubMed ID: 24839403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematin-hematin self-association states involved in the formation and reactivity of the malaria parasite pigment, hemozoin.
    Klonis N; Dilanian R; Hanssen E; Darmanin C; Streltsov V; Deed S; Quiney H; Tilley L
    Biochemistry; 2010 Aug; 49(31):6804-11. PubMed ID: 20593810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
    Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohols induce beta-hematin formation via the dissociation of aggregated heme and reduction in interfacial tension of the solution.
    Huy NT; Maeda A; Uyen DT; Trang DT; Sasai M; Shiono T; Oida T; Harada S; Kamei K
    Acta Trop; 2007 Feb; 101(2):130-8. PubMed ID: 17274939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonclassical mechanisms to irreversibly suppress β-hematin crystal growth.
    Ma W; Balta VA; Pan W; Rimer JD; Sullivan DJ; Vekilov PG
    Commun Biol; 2023 Jul; 6(1):783. PubMed ID: 37500754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The single crystal X-ray structure of β-hematin DMSO solvate grown in the presence of chloroquine, a β-hematin growth-rate inhibitor.
    Gildenhuys J; le Roex T; Egan TJ; de Villiers KA
    J Am Chem Soc; 2013 Jan; 135(3):1037-47. PubMed ID: 23253048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the influence of polymorph-dependent interfacial solvent structuring at chitin surfaces.
    Brown AH; Walsh TR
    Carbohydr Polym; 2016 Oct; 151():916-925. PubMed ID: 27474640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds.
    Ncokazi KK; Egan TJ
    Anal Biochem; 2005 Mar; 338(2):306-19. PubMed ID: 15745752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematin loses its membranotropic activity upon oligomerization into malaria pigment.
    Azouzi S; El Kirat K; Morandat S
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2952-9. PubMed ID: 26296297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition assay of beta-hematin formation initiated by lecithin for screening new antimalarial drugs.
    Trang DT; Huy NT; Uyen DT; Sasai M; Shiono T; Harada S; Kamei K
    Anal Biochem; 2006 Feb; 349(2):292-6. PubMed ID: 16376288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.